Demo
HLTH Nasdaq· Cue Health Inc.
FundamentalsNews digest Peer analysis
Login
HLTH Nasdaq· Cue Health Inc.
Earnings report Q3 2023

HLTH Reports Decrease in Revenue for the Latest Quarter

Segments of revenue

In the latest quarter, HLTH reported total revenue of $17.5 million, a significant decrease compared to $69.6 million in the same quarter of the previous year. The decrease in revenue was primarily volume-related, as the company experienced a tempering of COVID-19 testing, which continued into 2023. Revenue during the quarter was primarily driven by sales to private sector customers, amounting to $14.4 million.

Strengths

Despite the decrease in revenue, HLTH demonstrated strength in its ability to generate sales to private sector customers, contributing to the overall revenue for the quarter. The company's Cue Integrated Care Platform, which includes the Cue Health Monitoring System, Cue Data and Innovation Layer, Cue Virtual Care Delivery Apps, and Cue Ecosystem, continues to empower people to live their healthiest lives.

Challenges

The decrease in revenue for the latest quarter highlights the challenges faced by HLTH, particularly in relation to the tempering of COVID-19 testing. The company's reliance on COVID-19 testing as a significant revenue driver has been impacted by the changing landscape of the pandemic.

Noteworthy

It is worth noting that HLTH's revenue decrease in the latest quarter is primarily attributed to the volume-related impact of COVID-19 testing. The company's performance should be evaluated in the context of the ongoing pandemic and its effects on the healthcare industry.

Summary

HLTH reported a decrease in revenue for the latest quarter, primarily driven by the tempering of COVID-19 testing. Despite this challenge, the company demonstrated strength in generating sales to private sector customers. HLTH's Cue Integrated Care Platform continues to support its mission of empowering people to live their healthiest lives. The company's performance should be considered in the context of the ongoing pandemic and its impact on the healthcare industry.

Source documents

Form 10-Q  filed on Nov 08, 2023
60 pages scanned

Reference data

Company financials Q3 revenue 18.8M
Analyst estimates Q3 EPS missed by -25.19%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.